![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Bentham Science Publishers
E-ISSN: 1875-6166|8|4|241-248
ISSN: 1871-5249
Source: Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol.8, Iss.4, 2008-12, pp. : 241-248
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Drugs in Clinical Development for Alzheimer's Disease: Summary and Table†
Drugs & Aging, Vol. 29, Iss. 1, 2012-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Drugs in Clinical Development for Alzheimer's Disease: Summary and Table
Pharmaceutical Medicine, Vol. 25, Iss. 1, 2011-02 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
-Amyloid Disrupting Drugs: Potential in the Treatment of Alzheimer's Disease
By Soto C.
CNS Drugs, Vol. 12, Iss. 5, 1999-11 ,pp. :